CRI Clinical Innovator supports academic researchers leading early-phase cancer immunotherapy trials to test novel treatments, study response mechanisms, and identify biomarkers to improve patient outcomes.
CRI Clinic and Laboratory Integration Program supports investigator teams translating cancer immunology discoveries into immune-based approaches to prevent initial cancer development and recurrence.
CRI Impact Grant supports researchers conducting clinically relevant chordoma research that bridges laboratory and clinical discovery to translate immunological findings into cancer immunotherapies.
CRI Immuno-Informatics Postdoctoral Fellowship supports early-career scientists worldwide with research and training linking immunology and data science to advance cancer immunotherapy.
The CRI Irvington Postdoctoral Fellowship Program supports early-career scientists in immunology and cancer immunology research, fostering innovation and leadership through funding and mentorship from the Cancer Research Institute.